Venessa T. Chin
Sydney, NSW, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 57 publications
Real-world treatment sequencing and survival in ROS1-Rearranged NSCLC across evolving treatment eras: Findings from the AURORA multi-centre registry (AURORA-ROS1).
Journal: Lung cancer (Amsterdam, Netherlands)
Published: April 25, 2026
A roadmap for establishing institutional readiness for cellular therapies targeting solid tumours and autoimmune diseases.
Journal: NPJ precision oncology
Published: October 14, 2025
GDF15 biomarker performance in older patients with advanced non-small cell lung cancer.
Journal: Journal of geriatric oncology
Published: August 21, 2025
Assessing Second-Line Treatment Strategies and Outcomes in Epidermal Growth Factor Receptor (EGFR) Oncogene-Driven Stage IV Non-Small Cell Lung Cancer, Following a First-Line EGFR-TKI Therapy.
Journal: Cancer reports (Hoboken, N.J.)
Published: May 05, 2025
Long-Term Outcomes and Toxicities in Patients With Metastatic Non-Small Cell Lung Cancer Treated With Immunotherapy Containing Regimens.
Journal: Cancer reports (Hoboken, N.J.)
Published: March 04, 2025
Protein translation dysregulation and immune cell evasion mediated by IFN and immunoproteasome downregulation define metastatic clones in HPV-related cancer of the oropharynx.
Journal: BMC medicine
Published: December 19, 2024
Chemotherapy and radiotherapy for advanced pancreatic cancer.
Journal: The Cochrane database of systematic reviews
Published: December 05, 2024
Impact of COVID-19 on lung cancer care in New South Wales, Australia: real-world data from the EnRICH Program.
Journal: Public health research & practice
Published: October 23, 2024
Impact of COVID-19 on lung cancer care in New South Wales, Australia: real-world data from the EnRICH Program.
Journal: Public health research & practice
Published: October 23, 2024
Cardiac Substructure Dose and Survival in Stereotactic Radiotherapy for Lung Cancer: Results of the Multi-Centre SSBROC Trial.
Journal: Clinical oncology (Royal College of Radiologists (Great Britain))
Published: April 01, 2024
ALKTERNATE: A Pilot Study Alternating Lorlatinib With Crizotinib in ALK-Positive NSCLC With Prior ALK Inhibitor Resistance.
Journal: JTO clinical and research reports
Published: March 04, 2024
Last Updated: 09/26/2026